Paediatric antiretroviral use

Prezista (darunavir) has had its licence extended to include use in the treatment of HIV in antiretroviral-experienced children and adolescents over six years and weighing at least 20kg. Prezista should always be given in combination with low-dose ritonavir and other antiretrovirals.

View Prezista drug record

Further information: Janssen-Cilag

In addition, Aptivus (tipranavir) is now licensed for the treatment of HIV in highly pre-treated adolescents 12 years of age or older with virus resistant to multiple protease inhibitors. The drug should only be used as part of an active combination antiretroviral regimen in patients with no other therapeutic options.

View Aptivus drug record

Further information: Boehringer Ingelheim

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Topical Steroids, Comparison of Potencies and Formulations

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Topical Steroids, Potential Skin Sensitisers as Ingredients

Topical Steroids, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in topical steroids.